✦ LIBER ✦

PCN77 PHARMACOECONOMIC ANALYSIS OF ERLOTINIB COMPARED WITH DOCETAXEL FOR THE TREATMENT OF RELAPSED NON-SMALL-CELL LUNG CANCER (NSCLC) IN TURKEY

✍ Scribed by O Batigun; E Yildirim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN10 COST-EFFCTIVENESS ANALYSIS OF ERLO

✍ TC Hsia; GC Chang; YM Chen; MC Lin; WC Su; CM Tsai; CM Tsai; L Yang; J Creeden 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN11 PHARMACOECONOMIC ANALYSES OF ERLOT

✍ I Côté; NB Leighl; M Gyldmark; B Maturi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

CN4 COST-EFFECTIVENESS OF ERLOTINIB COMP

✍ G Lewis; L Morlotti; J Creeden; M Gyldmark; MD Peake 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCN21 BUDGET IMPACT ANALYSIS OF NON – SM

✍ E Orlewska; A Szczesna; M Szkultecka-Debek 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

PCN13: PHARMACOECONOMIC ANALYSIS OF ADVA

✍ C Rubio Terrés; JL Tisaire; S Kobina; A Moyano 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB